GlaxoSmithKline, the British pharmaceutical company, has offered Greek NGOs, including MSF, a special discount on its vaccine Synflorix, which has not been proven to protect children against pneumonia and other diseases, to encourage mass vaccination of migrants, offering a price of $3.05 per dose.
To repeat, there is limited data available showing that Synflorix is effective.
http://www.immune.org.nz/node/596
https://www.individuelle-impfentscheidung.de/index.php/impfen-mainmenu-14/3-pneumokokken
